[1]
“Interleukin-2 (Ronkoleykin) in the first-line chemotherapy of B-cell non-Hodgkin’s lymphoma”, Вопр. онкол., vol. 59, no. 2, pp. 52–58, Dec. 2013, doi: 10.37469/0507-3758-2013-59-2-52-58.